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Introduction
First blood vessels in a process, known as vasculogenesis, 
is formed from endothelial progenitor cells with novel 
specific patterns and gradually begin to spread, develop 
and form new branches (1). Formation of new blood 
vessels in adults is controlled precisely than previous 
vessels and angiogenesis just occurs in a physiological 
conditions such as pregnancy and specific pathological 
conditions such as wound healing, diabetic retinopathy, 
rheumatoid arthritis or cancer. Since angiogenesis is 
happened in pathological condition such as tumor 
growth and metastasis and plays an important role, it can 
also be targeted for antitumor therapy. In general, the 
process of angiogenesis is considered to have 10 stages 
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Implication for health policy/practice/research/medical education:
In this study saffron decreased the expression of MMP revealing an inhibitory effect on angiogenesis. This might be considered as a 
promising chemotherapeutic agent in breast cancer treatment.
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Introduction: There is an interest in Crocous sativus L. (Saffron) mainly because of its biological 
properties. Biomedical research has focused on saffron as a powerful antioxidant, anti-
inflammatory and anti-tumor, but its mechanism has not yet been thoroughly clarified. In this 
study, the effects of saffron aqua extract on matrix metalloproteinases (MMP) gene expression 
were investigated.
Methods: In this experimental study, the saffron was extracted using water as solvent. MCF-7 cells 
in RPMI1640 medium were supplemented with 10% FBS and incubated at 37 ˚C with 5% CO2. 
After 24 h, the cells were treated by saffron extract at concentrations of 100, 200, 400 and 800 
μg/ml. 48 h after treatment, total RNA was extracted and cDNA was synthesized using specific 
primer. Synthesized products were analyzed by Real Time PCR to determine expression level of 
MMP. 
Results: Data analysis showed inhibitory effect of saffron at concentrations of 100 to 800 µg/ml 
on MMP gene expression in comparison with control group. Reduction for 100, 200, 400 and 800 
µg/ml were 5%, 18%, 15%, 11%, respectively. According to data analysis treating MCF-7 cells with 
saffron at concentration of 200 µg/ml caused the highest decrease, with 18% reduction in gene 
expression (P<0.001).
Conclusion: Results indicate decrease in the expression of MMP compared with controls revealing 
induction of inhibitory effects of saffron on angiogenesis which might be also considered as a 
promising chemotherapeutic agent in breast cancer treatment.
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which one or more sequential steps could be targeted by 
angiogenesis inhibitors or simulators (2). This process 
is extensively depend on interactions between different 
cells and molecules and also is controlled by a variety 
of peptides and moderating factors (3). Several factors, 
such as vascular endothelial growth factor (VEGF), 
fibroblast growth factor (FGF), placental transforming 
growth factor (PTGF), signal transducer and activator 
of transcription 3 (STAT 3) are involved in this pathway 
(4). VEGF binding to vascular endothelial growth factor 
receptor 2 (VEGFR-2) triggers the speciﬁc activation of 
tyrosine amino acid residues within intra cytoplasmatic 
tail of the receptor inducing multiple signaling networks 
that result in endothelial cell survival, proliferation, 
migration, focal adhesion turnover, actin remodeling 
and vascular permeability. Signaling through mitogen-
activated protein kinase and phosphatidylinositol 3’ 
kinase is a common receptor tyrosine kinase activation 
pattern. Additional signaling pathways are also triggered 
upon VEGFR-2 activation, i.e., phospholipase C gamma, 
protein kinase focal adhesion kinase and T Cell-Speciﬁc 
Adaptor-Src kinase which are linked to migration and 
vascular permeability (5,6). Under hypoxic conditions, 
reduction of oxygen pressure is crucial and tissues start 
synthetizing and releasing angiogenic factors such as 
endothelial cell growth factors after binding to their 
special receptors, activating them which may lead to 
secretion of metalloproteinase from endothelial cells 
to digest and decompose basement membrane in the 
region. By reaching this aim endothelial cells would be 
able to migrate and proliferate. In addition, the molecule 
of adhesion such as integrins α7β5 and α3β7 are helpful 
in the process of pulling forward and bud blood vessels 
develop. In the next steps in the process of angiogenesis, 
matrix metalloproteinases (MMP) degrade extracellular 
matrix and start the production or reconstruction. By the 
interaction of the Tie-2 with angiopoietin tube formation 
begins at a later stage, EphB (ephrin B) also regulates 
formation of tubes, finally smooth muscle cells and 
pericytes as well as inducing the stabilization of newly 
formed blood vessel structure (7,8).
MMPs degrade and modify the extracellular matrix (ECM) 
as well as cell-ECM and cell-cell contacts, facilitating 
detachment of epithelial cells from the surrounding tissues 
(9). MMPs play key functions in embryonic development 
and mammary gland branching morphogenesis, but they 
are also up-regulated in breast cancer, where they stimulate 
tumorigenesis, cancer cell invasion and metastasis (10).
Rising cancer resistance to chemical therapies increased 
effort to find out new drugs in cancer therapy with fewer 
side effects and resistance (11). Cancer is growing in the 
world, and causes death of more than 6 million people each 
year, and breast cancer has the highest rates of mortality 
at ages of 40 (12,13). This cancer is hormone-dependent, 
which many of risk factors are known (14). Some of these 
risk factors are: geographic diversity, age, family history, 
pregnancy history, pregnancy, benign breast disease, 
exogenous estrogens, oral contraceptive drugs, obesity, 
high-fat diet, alcohol consumption, smoking and radiation 
chest out (15,16). 
Interfering with normal function of at least 4 to 6 genes 
by genetic and epigenetic mechanisms can lead to breast 
cancer, which disturb the balance between proliferation, 
apoptosis and differentiation, and also regulation of 
steroid receptors, binding cells and angiogenesis (17,18).
Saffron, the stigma of Crocus sativus L. (Iridaceae), is 
currently used as spice, source of food additives, colorants 
and as a component of traditional medicines (19). This 
biomedical herb contains many constituents such as 
crocetin, picrocrocin and volatile compounds including 
safranal, crocins and crocetin (20,21). Saffron has been 
evaluated for its pharmacological activities such as 
anti-cancer, and antitumor and its constituents showed 
antioxidant activity in different organs such as muscle, 
kidney and hippocampus. Recent studies demonstrated 
the antitumor properties of saffron both in vitro and in 
vivo (22). 
As regards to identification an effective strategy by using 
new agents from natural sources to treatment cancers, 
and since matrix metalloproteinase (MMP) is potent 
endothelial mitogen that up regulated in number of tumor 
types, including breast cancer, the aim of this study was to 
investigated the effect of saffron aqueous extract on level 
of MMP in human breast cancer cell line (MCF-7).
Materials and Methods
Saffron sample preparation
Original Iranian saffron (Crocus sativus L.) which 
is widely grown and gathered at autumn in south of 
Khorasan province was purchased from Novin Zaferan Co 
(Mashhad, Iran) and was identified by a plant taxonomist 
from the Herbarium Division of the College of Ferdowsi 
University. The stigma’s aqueous extract was prepared as 
follow: 3 g dried stigmas was extracted with 250 ml sterile 
distilled water by soxhlet apparatus. The mixtures were 
transferred to Rotary to remove water. In order to dry, the 
extract lyophilization was done by using freeze dryer.
Cell culture and treatment
MCF7 cells were obtained from Pasteur Institute, Iran. 
Cells were cultured in RPMI medium (Biosera, Iran) 
with 10% fetal bovine serum (Gibco, USA), 100 units/ml 
penicillin, and 100 µg/ml streptomycin (Sigma, France ) 
and also 1 ml L-glutamine (Sigma, France ). Then, it was 
incubated at 37 ˚ C with 5% CO2. 24 h after cell culture and 
insurance about cell adhesion to flask, cells were treated 
with aqueous extract of saffron at concentrations of 100, 
200, 400 and 800 micrograms per ml. Then to evaluate 
the viability, Trypan blue (Sigma, France) test was used 
and pictures captured with a digital camera with invert 
microscope (Dinocapture) for 5 days to investigate cell 
morphological changes.
Effect of saffron on MMP gene expression
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RNA extraction
RNA was extracted by total RNA purification kit 
(Bioscience, Germany). After 48 h of treatment, the 
total RNA was purified and stored at -20 °C until cDNA 
synthesis. To measure the amount of RNA, Nanodrop 
was used by wavelengths 260, 280 and 320 nm and data 
were measured and analyzed. These data indicate the 
concentration of the extracted RNA which was used for 
cDNA synthesis as follow:
RNA concentration = (OD 260 - OD 320) × 40 × 100
cDNA synthesis
cDNA was synthesized by Bioneer Kit (Korea), the 
temperature of synthesis was according to Table 1.
Synthesis of primers
The sequence of genes was received from NCBI site and 
the bio-informatic validation of RT-PCR primers were 
done in PRIMER BLAST and delivered Bioneer Company 
(Korea). Primers were designed according to Table 2.
Evaluation of gene expression using real time PCR
Process of real time PCR to study gene expression was done 
according to the protocol by Bioneer kit (South Korea) by 
Applied Biosystem. According to the protocol, Master Mix 
firstly was prepared and added to strip cap microtube and 
then the cDNA was added to it. Application temperature 
according Tm of designed primers and the characteristics 
of the different phases in polymerase chain reaction were 
determined. 
Gene expression levels of MMP in samples exposed low 
frequency electromagnetic field in comparison with 
control samples were analyzed by SPSS (V.16). P-value 
of less than 0.05 and CI (Confidence Interval) 95% were 
accepted as significant. In this project, we used relative 
quantitative based on expression of target gene to the 
reference gene via comparing the target gene efficiency 
with control sample. The primer and the temperature of 
binding primer are essential factors in the optimization 
of Real Time PCR reaction. So condition of reaction 
was optimized in which no nonspecific products 
Table 1. The temperature required for the synthesis of cDNA
Steps Temperature Time (min)
Primer annealing Tm of specific primer 1 
cDNA synthesis 42-70 °C 10 – 60 
Heat inactivation 95 °C 5 
Table 2. Sequences of genes
Gene Forward 5'→3' Reverse 5'→3' Chromosomal 
location
Βeta actin CCC GCC GCC AGC 
TCA CCA TGG
AAG GTC TCA AAC 
ATG ATC TGG GTC
7p22
MMP CTG CAT CCT CAG 
CAG GTTG
GTC TCG GAT AGT 
CTT TAT CC
1q 
26422762-
26426467bp
produced. This optimized condition observed by mono 
peak in melting curve and also electrophoresis in agar 
gel by looking single sharp band. The mean ± SD were 
determined for each study group. Data were analyzed 
by ANOVA & Tukey multiple comparison procedure to 
calculate the signiﬁcance. P<0.05 value between study 
groups was taken as statistically signiﬁcant.
Results
Gene expression studies showed a significant reduction 
in the gene expression levels of MMP gene treated with 
concentrations of 100 (P<0.05), 200 (P<0.001), 400 
(P<0.05) and 800 (P<0.05) micrograms per ml of cells in 
comparison with the control group (Figure 1). Also data 
analysis showed inhibitory effect of saffron extract at 
concentrations of 100, 200, 400 and 800 μg/ml on MMP 
gene expression with 5%, 18%, 15% and 11% respectively in 
MCF-7 cell line in comparison with control group. As data 
indicate significant inhibitory effect on gene expression of 
MMP was 18% in 200 μg/ml of saffron extract. 
Since the PCR reaction efficiency between the target gene 
and the housekeeping gene (beta-actin) was the same, the 
comparative threshold cycle (CT) was used in this project. 
It was examined whether the CT variance scale down by 
using dilution standard samples with quantity of 100, 10, 
0.1, and 0.01 or not? Data analysis revealed that by dilution 
of samples CT changed and scale down. Acceptable data 
with high efficiency are represented in Figure 2.
Discussion
In this research, we investigated the effect of saffron 
extract on MMP level in human breast cancer cells. Since 
extracellular proteolysis mediates tissue homeostasis and 
in cancer, altered proteolysis leads to unregulated tumor 
growth, tissue remodeling, inflammation, tissue invasion, 
and metastasis, so the MMPs represent the most prominent 
family of proteinases associated with tumorigenesis. Also 
while MMPs regulate signaling pathways that control cell 
growth, inflammation, or angiogenesis, the study of MMP 
function may be new approaches to cancer therapy (23). 
Figure 1. MMP gene expression in samples treated with saffron 
aqueous extract in different concentration compared with control 
group; * P<0.05, **P<0.001.
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Figure 2. CT scale down by using dilution standard samples with 
quantity of 100, 10, 0.1, and 0.01.
Previously it was revealed that inhibition of MMP with two 
murine models could lead to decrease angiogenesis and 
MMPs may be a target in cancer treatment and inhibition 
of metastasis (24). Another research in 2009 indicated 
EGFR activation led to enhanced MMP expression and/
or function, and suggested that modulating the expression 
or activity of the EGFR and/or matrix metalloproteinases 
offers opportunity for targeted intervention in patients 
with metastatic disease (25).
It has been demonstrated that saffron’s main component 
such as crocin, crocetin and safranal could inhibit 
neurons erosion and depression (21). Result of a research 
in 2009 revealed that angiogenesis inhibition with natural 
products seemed to be useful and promising method 
in order to encounter less resistance (22). There are 
several mechanisms for the antitumor effect of saffron 
and its components, including inhibition of nucleic 
acid, scavenging free radical, effect on the expression 
of topoisomerase 2, and induction of programmed cell 
death. Furthermore, it could reduce cancer, decline the 
rate of tumor cell and significantly increase the lifelong of 
animal (26). It is indicated that saffron in different tumors, 
including leukemia, ovarian and breast carcinoma had 
anticancer and selective cytotoxic effect on different 
malignant cells (27). Moreover, saffron had cancer-
preventive and anti genotoxic potential, so it would be 
used in combination with chemotherapy. Saffron has been 
shown reduce potential against lipid peroxidation and at 
the same time increase the enzymatic antioxidants like 
superoxide dismutase and catalase and non-enzymatic 
antioxidants such as liver glutathione regeneration (28). 
In addition, safranal increased tissue oxygen which 
have sweeping effect on free radicals and could inhibit 
oxidative stress of genotoxic compounds. Safranal also had 
protective effect on lipid peroxidation; since angiogenesis 
shows direct relation with tissue oxygen and hypoxia 
is one of the most important simulator of angiogenesis, 
increasing tissue oxygen accompanied. Saffron treatment 
may explain some part of anti-angiogenic effect of this 
herb (29). Results of another research represented that 
saffron had antitumor effects on TCC cell line (related to 
bladder cancer) in a time- and dose-dependent manner 
in a way that in high concentration the percentage of 
vital cells declined dramatically (30). Results of these 
researches were consistent with the findings of the present 
project. Influential potential of saffron on the induction or 
inhibition of gene expression in few cases has been studied 
so far. However, Mousavi et al. studied the effect of saffron 
extract on the level of protein which was related to apoptosis 
such as bax protein and enzyme as influential as caspase 
in breast cancer cells and represent that using saffron 
extract could reduce cell viability dose-dependently (31). 
The result on the induction of apoptosis of saffron extract 
depicts that on hepatocarcinoma and cervix cells extract 
showed significant cytotoxic effects (32). These results 
were coincided with our findings and cancer cell growth 
inhibited by the extract on concentration-dependent 
manner. In this research, saffron extract could reduce the 
level of MMP and gene expression decline which shows 
conformity with other data that reveals cytotoxic and 
anticancer effect of saffron. 
Conclusion
The results of this study indicate reduction in MMP 
gene expression in breast cancer cells treated with 
the saffron aqueous extract. This may show the anti-
angiogenic potential of this medical herb as a promising 
chemotherapeutic agent, and its potential in prevention of 
angiogenesis and metastasis.
Acknowledgments
The authors gratefully thank the colleagues in Research 
Center for Animal Development Applied Biology of 
Islamic Azad University of Mashhad (Mashhad, Iran) and 
also Department of Biophysics for their help and kind 
support.
Authors’ contributions
JB designed and supervised the experiments, analyzed the 
data and wrote the paper; MM performed experiments, 
analyzed data and wrote the paper; MAS designed, 
analyzed data and wrote and edited the paper.
Conflict of interests
The authors declare no conflict of interest.
Ethical considerations 
Ethical issues (including plagiarism, misconduct, 
data fabrication, falsification, double publication or 
submission, redundancy) have been completely observed 
by the authors. 
Effect of saffron on MMP gene expression
Journal of HerbMed Pharmacology, Volume 3, Number 2, December 2014http://www.herbmedpharmacol.com 105
Funding/Support
This work was financially supported by the Research 
Center for Animal Development Applied Biology, 
Mashhad Branch, Islamic Azad University, Mashhad, Iran
References
1. Hendrix MJ, Seftor EA, Seftor REB. Vasculogenic 
Mimicry: Angiogenesis in Disguise? In: Forough R, 
editor. New Frontiers in Angiogenesis. Netherlands: 
Springer; 2006. 
2. Fayette J, Soria JC, Armand JP. Use of angiogenesis 
inhibitors in tumour treatment. Eur J Cancer 2005; 
41(8):1109–16.
3. Breier G. Vasculogenesis. In: Unsicker K, Krieglstein 
K, editors. Cell Signaling and Growth Factors in 
Development: From Molecules to Organogenesis. 1 ed. 
Weinheim, Germany: Wiley-VCH Verlag GmbH; 2008.
4. Guo S, Colbert LS, Fuller M, Zhang Y, Gonzalez-Perez RR. 
Vascular endothelial growth factor receptor -2 in breast 
cancer. Biochim Biophys Acta 2010; 1806(1): 108-21.
5. Olsson AK, Dimberg A, Kreuger J, Claesson-Welsh 
L. VEGF receptor signalling— in control of vascular 
function. Nat Rev Mol Cell Biol 2006; 7(5): 359–71.
6. Solowiej J, Bergqvist S, McTigue MA, Marrone T, Quenzer 
T, Cobbs M, et al. Characterizing the effects of the 
juxtamembrane domain on vascular endothelial growth 
factor receptor-2 enzymatic activity, autophosphorylation, 
and inhibition by axitinib. Biochemistry 2009; 
48(29):7019-31.
7. Singh AJ, Meyer RD, Band H, Rahimi N. The carboxyl 
terminus of VEGFR-2 is required for PKC-mediated 
down-regulation. Mol Biol Cell 2005; 16(4):2106-18.
8. Brooks SA, Lomax-Browne HJ, Carter TM, Kinch CE, 
Hall DM. Molecular interactions in cancer cell metastasis. 
Acta Histochem 2010; 112(1):3-25.
9. Nisato RE, Hosseini G, Sirrenberg C, Butler GS, 
Crabbe T, Docherty AJ, et al. Dissecting the role of 
matrix metalloproteinases (MMP) and integrin αvβ3 in 
angiogenesis in vitro: absence of hemopexin C domain 
bioactivity, but membrane-type 1-MMP and αvβ3 are 
critical. Cancer Res 2005; 65(20):9377-87. 
10. Radisky ES, Radisky DC. Matrix Metalloproteinase-
Induced Epithelial-Mesenchymal Transition in Breast 
Cancer. J Mammary Gland Biol Neoplasia 2010; 
15(2):201–12.
11. Bhat TA, Singh RP. Tumor angiogenesis – A potential 
in cancer chemoprevention. Food Chem Toxicol 2008; 
46(4):1334-45.
12. Kummalue T. Molecular mechanism of herbs in human 
lung cancer cells. J Med Assoc Thai 2005; 88(11):1725-34.
13. Mousavi SM, Montazeri A, Mohagheghi MA, Jarrahi 
AM, Harirchi I, Najafi M, et al. Breast cancer in Iran: an 
epidemiological review. Breast J 2007; 13(4):383-91.
14. Harirchi I, Karbakhsh M, Kashefi A, Momtahen AJ. Breast 
cancer in Iran: results of a multi-center study. Asian Pac J 
Cancer Prev 2004; 5(1):24-7.
15. Cristofanilli M, Broglio KR, Guarneri V, Jackson S, 
Fritsche HA, Islam R, et al. Circulating tumor cells in 
metastatic breast cancer biology staging beyond tumor 
burden. Clin Breast Cancer 2007; 7(6):471-9.
16. Rudel RA, Fenton SE, Ackerman JM, Euling SY, 
Makris SL. Environmental exposures and mammary 
gland development: state of the science, public health 
implications, and research recommendations. Environ 
Health Perspect 2011; 119(8):1053. 
17. Fernández JA, Pandalai S. Biology, biotechnology and 
biomedicine of saffron. Recent Res Devel Plant Sci 2004; 
2:127-59.
18. Kaefer CM, Milner JA. The role of herbs and spices in 
cancer prevention. J Nutr Biochem 2008; 19(6): 347-61.
19. Melnyk JP, Wang S, Marcone MF. Chemical and biological 
properties of the world’s most expensive spice: saffron. 
Food Res Int 2010; 43(8):1981-9.
20. Ochiai T, Shimeno H, Mishima K, Iwasaki K, Fujiwara 
M, Tanaka H, et al. Protective effects of carotenoids from 
saffron on neuronal injury invitro and invivo. Biochim 
Biophys Acta 2007; 1770(4): 578-84.
21. Premkumar K, Thirunavukkarasu C, Abraham SK, 
Santhiya ST, Ramesh A. Protective effect of saffron 
(Crocus sativus L.) aqueous extract against genetic 
damage induced by anti-tumor agents in mice. Hum Exp 
Toxicol 2006; 25(2):79-84.
22. Abd Majid FA, Sarmidi MR, SH C. Impact of saffron as an 
anti-cancer and anti-tumor herb. Afr J Pharma Pharmacol 
2010; 4(11):834-40. 
23. Kessenbrock K, Plaks V, Werb Z. Matrix metalloproteinases: 
regulators of the tumor microenvironment. Cell 2010; 
141(1):52-67. 
24. Naglich JG, Jure-Kunkel M, Gupta E, Fargnoli J, 
Henderson AJ, Lewin AC, et al. Inhibition of angiogenesis 
and metastasis in two murine models by the matrix 
metalloproteinase inhibitor, BMS-275291. Cancer Res 
2001; 61(23):8480-5. 
25. Hudson LG, Moss NM, Stack MS. EGF-receptor 
regulation of matrix metalloproteinases in epithelial 
ovarian carcinoma. Future Oncol 2009; 5(3):323–38.
26. Schmidt M, Betti G, Hensel A. Saffron in phytotherapy: 
pharmacology and clinical uses. Wien Med Wochenschr 
2007; 157(13-14):315-9. 
27. Melnyk JP, Wang S, Marcone MF. Chemical and biological 
properties of the world’s most expensive spice: saffron. 
Food Res Int 2010; 43(8):1981-9.
28. Ochiai T, Soeda S, Ohno S, Tanaka H, Shoyama Y, Shimeno 
H. Crocin prevents the death of PC-12 cells through 
sphingomyelinase-ceramide signaling by increasing 
glutathione synthesis. Neurochem Int 2004; 44(5):321-30. 
29. Holloway GM, Gainer JL. The carotenoid crocetin 
enhances pulmonary oxygenation. J Appl Physiol 1988; 
65(2):683-6.
30. Feizzadeh B, Afshari JT, Rakhshandeh H, Rahimi A, 
Brook A, Doosti H. Cytotoxic effect of saffron stigma 
aqueous extract on human transitional cell carcinoma and 
mouse fibroblast. Urol J 2008; 5 (3):161-7. 
31. Mousavi SH, Tavakkol-Afshari J, Brook A, Jafari-
Anarkooli I. Role of caspases and Bax protein in saffron-
induced apoptosis in MCF-7 cells. Food Chem Toxicol 
2009; 47(8):1909-13.
32. Tavakkol-Afshari J, Brook A, Mousavi SH. Study of 
cytotoxic and apoptogenic properties of saffron extract 
in human cancer cell lines. Food Chem Toxicol 2008; 
46(11):3443-7.
